chr15-66703548-G-A

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The ENST00000288840.10(SMAD6):​c.290G>A​(p.Gly97Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,221,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G97G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00081 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000061 ( 0 hom. )

Consequence

SMAD6
ENST00000288840.10 missense

Scores

2
3
14

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts U:1B:2

Conservation

PhyloP100: 2.99
Variant links:
Genes affected
SMAD6 (HGNC:6772): (SMAD family member 6) The protein encoded by this gene belongs to the SMAD family of proteins, which are related to Drosophila 'mothers against decapentaplegic' (Mad) and C. elegans Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein functions in the negative regulation of BMP and TGF-beta/activin-signalling. Multiple transcript variants have been found for this gene.[provided by RefSeq, Sep 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11071277).
BP6
Variant 15-66703548-G-A is Benign according to our data. Variant chr15-66703548-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 405513.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000806 (122/151318) while in subpopulation AFR AF= 0.0028 (116/41446). AF 95% confidence interval is 0.00238. There are 0 homozygotes in gnomad4. There are 52 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 122 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SMAD6NM_005585.5 linkuse as main transcriptc.290G>A p.Gly97Glu missense_variant 1/4 ENST00000288840.10 NP_005576.3
SMAD6NR_027654.2 linkuse as main transcriptn.1313G>A non_coding_transcript_exon_variant 1/5
SMAD6XR_931827.3 linkuse as main transcriptn.1313G>A non_coding_transcript_exon_variant 1/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SMAD6ENST00000288840.10 linkuse as main transcriptc.290G>A p.Gly97Glu missense_variant 1/41 NM_005585.5 ENSP00000288840 P1O43541-1
SMAD6ENST00000557916.5 linkuse as main transcriptc.290G>A p.Gly97Glu missense_variant, NMD_transcript_variant 1/51 ENSP00000452955 O43541-4
SMAD6ENST00000612349.1 linkuse as main transcriptn.472G>A non_coding_transcript_exon_variant 1/1

Frequencies

GnomAD3 genomes
AF:
0.000807
AC:
122
AN:
151210
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00281
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000132
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.0000443
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000607
AC:
65
AN:
1070540
Hom.:
0
Cov.:
31
AF XY:
0.0000651
AC XY:
33
AN XY:
506754
show subpopulations
Gnomad4 AFR exome
AF:
0.00258
Gnomad4 AMR exome
AF:
0.000258
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000219
Gnomad4 OTH exome
AF:
0.0000473
GnomAD4 genome
AF:
0.000806
AC:
122
AN:
151318
Hom.:
0
Cov.:
32
AF XY:
0.000703
AC XY:
52
AN XY:
73960
show subpopulations
Gnomad4 AFR
AF:
0.00280
Gnomad4 AMR
AF:
0.000132
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000443
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000427
Hom.:
0
Bravo
AF:
0.000827
ExAC
AF:
0.0000715
AC:
4
Asia WGS
AF:
0.000312
AC:
1
AN:
3218

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The SMAD6 p.Gly97Glu variant was not identified in the literature nor was it identified in LOVD 3.0. The variant was identified in dbSNP (ID: rs566777509) and ClinVar (classified as likely benign by Invitae). The variant was identified in control databases in 25 of 34258 chromosomes at a frequency of 0.0007298 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: African in 22 of 8598 chromosomes (freq: 0.002559), Other in 1 of 1044 chromosomes (freq: 0.000958) and European (non-Finnish) in 2 of 15732 chromosomes (freq: 0.000127), but was not observed in the Latino, Ashkenazi Jewish, East Asian, European (Finnish), or South Asian populations. The p.Gly97 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 28, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Aortic valve disease 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 05, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.33
T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.25
FATHMM_MKL
Benign
0.24
N
LIST_S2
Benign
0.50
T
M_CAP
Pathogenic
0.92
D
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.67
T
MutationAssessor
Benign
1.6
L
MutationTaster
Benign
0.98
D;D
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-0.41
N
REVEL
Benign
0.26
Sift
Uncertain
0.0070
D
Sift4G
Uncertain
0.012
D
Polyphen
0.51
P
Vest4
0.039
MVP
0.62
MPC
1.5
ClinPred
0.76
D
GERP RS
4.1
Varity_R
0.22
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs566777509; hg19: chr15-66995886; API